| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) | 
|---|
| 03/12/2014 | CN102215667B Plant having resistance to multiple diseases and method for production thereof | 
| 03/12/2014 | CN102212554B Enterovirus type 71 (EV71) infectious clone and construction method | 
| 03/12/2014 | CN102199668B Nano-particle molecule haplotype typing technique | 
| 03/12/2014 | CN102197306B Immobilization substrate and method for producing same | 
| 03/12/2014 | CN102186978B Compositions and methods for inhibiting expression of transthyretin | 
| 03/12/2014 | CN102165317B Process for producing microbeads and microbeads | 
| 03/12/2014 | CN102154272B Primer set for amplification of obesity gene, reagent for amplification of obesity gene comprising primer set, and use of primer set | 
| 03/12/2014 | CN102151337B Compositions and methods for regulated protein expression in gut | 
| 03/12/2014 | CN102137927B Methods for identifying fragile histidine triad (Fhit) interaction and uses thereof | 
| 03/12/2014 | CN102134578B Application of TT1 gene to improvement of heavy metal resistance of plants and microorganisms | 
| 03/12/2014 | CN102131934B Plants having enhanced yield-related traits and method for making same | 
| 03/12/2014 | CN102115750B Application of TT1 gene to improvement of plant yield | 
| 03/12/2014 | CN102112146B Immunity inducer | 
| 03/12/2014 | CN102105482B Nucleoside triphosphate derivative, nucleic acid probe, multilabeled nucleic acid probe, method for production of multilabeled nucleic acid probe, and method for detection of target nucleic acid | 
| 03/12/2014 | CN102085377B Immunogenic composition and methods | 
| 03/12/2014 | CN102071219B Improved adenovirus vector and application thereof in medicine for preventing and treating AIDS (Acquired Immure Deficiency Syndrome) | 
| 03/12/2014 | CN102066552B Cellular production of glucaric acid | 
| 03/12/2014 | CN101998965B Immunosuppressive polypeptides and nucleic acid | 
| 03/12/2014 | CN101970443B RNA-selective hybridization reagent and utilization of same | 
| 03/12/2014 | CN101960012B Woody plants having improved growth charateristics and method for making same using transcription factors | 
| 03/12/2014 | CN101921841B HLA (Human Leukocyte Antigen) gene high-resolution genotyping method based on Illumina GA sequencing technology | 
| 03/12/2014 | CN101921310B Dengue virus (DENV) specific HLA-A2 (Human Leukocyte Antigen-A2) restrictive epitope peptide and application thereof | 
| 03/12/2014 | CN101884784B Bv8 nucleic acids and polypeptides with mitogenic activity | 
| 03/12/2014 | CN101880688B Method for selectively replicating replication-defective adenovirus and application | 
| 03/12/2014 | CN101809161B Method of producing heterogeneous protein | 
| 03/12/2014 | CN101802194B Methods for improving protein performance | 
| 03/12/2014 | CN101755049B Primary micro RNA expression cassette | 
| 03/12/2014 | CN101712637B Labeled compound and detection method using same | 
| 03/12/2014 | CN101679966B Genetically recombinant antibody composition having enhanced effector activity | 
| 03/12/2014 | CN101679521B Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind CD154 and uses thereof | 
| 03/12/2014 | CN101617043B Nuclear reprogramming method | 
| 03/12/2014 | CN101563457B Method for purifying RNA on preparative scale by means of HPLC | 
| 03/12/2014 | CN101541960B Partial fragment of REIC/Dkk-3 gene and therapeutic agent for cancer containing same | 
| 03/12/2014 | CN101501207B Synthetic genomes | 
| 03/12/2014 | CN101460054B Mature dendritic cell compositions and methods for culturing same | 
| 03/12/2014 | CN101418044B Immunoglobulin variants and uses thereof | 
| 03/12/2014 | CN101415829B Plants having enhanced yield-related traits and method for making same | 
| 03/12/2014 | CN101261277B Promyostatin peptides and methods of using same | 
| 03/11/2014 | US8669441 Plants and seeds of hybrid corn variety CH602747 | 
| 03/11/2014 | US8669440 Plants and seeds of hybrid corn variety CH007769 | 
| 03/11/2014 | US8669439 Plants and seeds of hybrid corn variety CH140757 | 
| 03/11/2014 | US8669438 Maize hybrid X13C763 | 
| 03/11/2014 | US8669437 Maize variety hybrid X13A464 | 
| 03/11/2014 | US8669434 Soybean variety A1026708 | 
| 03/11/2014 | US8669433 Soybean variety A1026705 | 
| 03/11/2014 | US8669425 Soybean variety XB45K12 | 
| 03/11/2014 | US8669424 Soybean variety XB47R12 | 
| 03/11/2014 | US8669422 Canola hybrid cultivar CL166102H | 
| 03/11/2014 | US8669421 Dover lettuce variety | 
| 03/11/2014 | US8669420 Hybrid artichoke variety NUN 4060 AR | 
| 03/11/2014 | US8669419 Engineering broad and durable resistance to grapevine fanleaf virus in plants | 
| 03/11/2014 | US8669418 Means and methods for mediating protein interference | 
| 03/11/2014 | US8669417 Methods and compositions for increasing plant transformation efficiency | 
| 03/11/2014 | US8669379 Microbial production of 3,4-dihydroxybutyrate (3,4-DHBA), 2,3-dihydroxybutyrate (2,3-DHBA) and 3-hydroxybutyrolactone (3-HBL) | 
| 03/11/2014 | US8669350 TNF receptor Fc fusion proteins and in vivo methods of use | 
| 03/11/2014 | US8669345 Nogo receptor antagonists | 
| 03/11/2014 | US8669239 Methods of inhibiting tumor cell aggressiveness using the microenvironment of human embryonic stem cells | 
| 03/11/2014 | US8669238 Use of Kif13A and AP-1 inhibitors for inhibiting melanogenesis | 
| 03/11/2014 | US8669237 Biodegradable immunomodulatory formulations and methods for use thereof | 
| 03/11/2014 | US8669236 Biotinylated compositions | 
| 03/11/2014 | US8669235 Modulation of innate immunity receptors' signaling by microRNAs miR-146a and miR-146b | 
| 03/11/2014 | US8669109 Methods of producing proteins in Chinese hamster ovary (CHO) cells | 
| 03/11/2014 | US8669108 Gene expression control in plants | 
| 03/11/2014 | US8669103 Oplophorus-derived luciferases, novel coelenterazine substrates, and methods of use | 
| 03/11/2014 | US8669102 Modulation of prion expression | 
| 03/11/2014 | US8669101 Bacterially derived intact minicells that encompass plasmid free functional nucleic acid for in vivo delivery to mammalian cells | 
| 03/11/2014 | US8669100 DNA expression constructs encoding the Leishmania infantum antigens thiol-specific antioxidant protein and kinetoplastid membrane protein | 
| 03/11/2014 | US8669098 Bio-microarray and a substrate for use therewith | 
| 03/11/2014 | US8669092 Urocortin-III and uses thereof | 
| 03/11/2014 | US8669089 Ulvan lyase, method for manufacturing same, and uses thereof | 
| 03/11/2014 | US8669088 Enzyme associated with equol synthesis | 
| 03/11/2014 | US8669087 Luciferase mutant | 
| 03/11/2014 | US8669082 Single vessel production of butanol from biomass using engineered thermophilic microorganisms | 
| 03/11/2014 | US8669078 Ammonia-specific 5′-XMP aminase mutant | 
| 03/11/2014 | US8669073 Compositions of orthogonal lysyl-tRNA and aminoacyl-tRNA synthetase pairs and uses thereof | 
| 03/11/2014 | US8669062 Disease detection by digital protein truncation assays | 
| 03/11/2014 | US8669051 Substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system | 
| 03/11/2014 | US8668933 Polyion complex of double-stranded ribonucleic acid | 
| 03/11/2014 | US8668909 Anti MIF antibodies | 
| 03/11/2014 | CA2810915C Xylitol-producing strain to which an arabinose metabolic pathway is introduced, and method for producing xylitol using same | 
| 03/11/2014 | CA2612458C Use of hydrophobin-polypeptides and conjugates from hydrophobin-polypeptides having active and effect agents and the production thereof and use thereof in the cosmetic industry | 
| 03/11/2014 | CA2586048C Protection against herbivores | 
| 03/11/2014 | CA2567449C Antibodies and related molecules that bind to psca proteins | 
| 03/11/2014 | CA2562552C Hybrid recombinases for genome manipulation | 
| 03/11/2014 | CA2531684C Binding molecules against sars-coronavirus and uses thereof | 
| 03/11/2014 | CA2501851C Circular dna molecule having a conditional origin of replication, process for their preparation and their use in gene therapy | 
| 03/11/2014 | CA2495198C Novel lipases and uses thereof | 
| 03/11/2014 | CA2470414C Egvi endoglucanase and nucleic acids encoding the same | 
| 03/11/2014 | CA2424856C Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods | 
| 03/11/2014 | CA2418370C Modified yeasts and uses thereof, in particular for producing steroid derivatives | 
| 03/11/2014 | CA2396428C Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby | 
| 03/06/2014 | WO2014036524A2 Genetically modified msc and therapeutic methods | 
| 03/06/2014 | WO2014036468A2 Aav mediated aquaporin gene transer to treat sjogren's syndrome | 
| 03/06/2014 | WO2014036429A1 Mirna modulators of chronic visceral inflammation | 
| 03/06/2014 | WO2014036427A1 Biotin complexes for treatment and diagnosis of alzheimer's disease | 
| 03/06/2014 | WO2014036404A2 Crowding agent-induced nucleic acid transfer into a recipient host cell | 
| 03/06/2014 | WO2014036385A1 Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (igf-1) | 
| 03/06/2014 | WO2014036349A1 Expression of chimeric ksac protein and method of producing soluble proteins by high pressure | 
| 03/06/2014 | WO2014036345A2 Hyperbaric device and methods for producing inactivated vaccines and for refolding/solubilizing recombinant proteins | 
| 03/06/2014 | WO2014036313A1 Use of aldh7 for improved stress tolerance |